Condition

IPMN, Pancreatic clinical trials and research

• 7Clinical trials
• 4Countries

Newest IPMN, Pancreatic clinical trials

All recruiting trials (7)

• Biophotonic blood test to spot pancreatic cancer risk in at‑risk adults

  A blood test using light-based technology is being tested to see if it can predict pancreatic cancer development in people at risk, and also check how well treatments work for those affected.

  Recruiting Fondazione Policlinico Universitario Campus Bio-Medico · Rome, Italy · NCT07659639

• AI-guided decision support for managing pancreatic conditions

  This project will test an AI tool that reads contrast-enhanced CT scans to help doctors decide whether people with suspected pancreatic disease need surgery, close monitoring, or routine follow-up.

  Recruiting Changhai Hospital · Shanghai · NCT07439757

• Preventing complications after high-risk Whipple (pancreatoduodenectomy) with hydrocortisone, octreotide, and a teres ligament patch

  This tests whether giving hydrocortisone and octreotide around surgery plus placing a teres ligament patch can lower major complications after Whipple surgery in patients with a small pancreatic duct.

  Recruiting Phase 4 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT07262957

• Using multi-omics markers to find invasive IPMNs

  This project tests whether combining genetic, metabolic, transcriptomic and environmental markers can help identify which adults with IPMNs have or will develop invasive pancreatic cancer.

  Recruiting IRCCS San Raffaele · Milan, MI · NCT06694792

• New biomarkers to predict which pancreatic IPMNs will progress

  This project will test whether tissue and blood biomarkers can help predict which adults with IPMN will progress to invasive pancreatic cancer.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma and 1 other locations · NCT06574373

• Database to predict pancreatic cancer from IPMN

  This study is trying to build a database to help understand how a specific type of pancreatic growth called IPMN can turn into pancreatic cancer, so we can improve early detection and treatment for patients.

  Recruiting St Vincent's Hospital Melbourne · Fitzroy, Victoria · NCT05117723

• Innovative therapies for liver metastases in cancer patients

  This study is testing new ways to understand and treat liver tumors in patients with advanced colorectal and pancreatic cancer to see if it can lead to better therapies.

  Recruiting IRCCS San Raffaele · Milan, Milan · NCT04622423

Related topics

Quick answers

How many IPMN, Pancreatic clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in Italy (4 trials), Australia (1 trial), Netherlands (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →